Stock Scorer

Organon & Co. (OGN)

Organon & Co. reported revenue of 1.6B USD for the quarter ending 30 June 2026, down 2.3% from 1.6B a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q2 '26 · ending 30 June 2026 1.6B -2.3%
Gross Profit Q2 '26 · ending 30 June 2026 847M -3.1%
Net Income Q2 '26 · ending 30 June 2026 108M +24.1%
Cost of Revenue Q2 '26 · ending 30 June 2026 711M -1.2%
Operating Cash Flow Q2 '26 · ending 30 June 2026 107M -51.4%
Free Cash Flow Q2 '26 · ending 30 June 2026 65M -64.1%
Shares Outstanding Q2 '26 · ending 30 June 2026 270.4M +3.6%
EPS Q3 '25 · ending 30 September 2025 1.91 -62.1%

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 6.2B—187M538M
20242024-12-31 6.4B—864M764M
20232023-12-31 6.3B—1B548M
20222022-12-31 6.2B—917M662M
20212021-12-31 6.3B—1.4B2B
20202020-12-31 6.5B—2.2B2B
20192019-12-31 7.8B—3.2B2.9B

Every period

Revenue Quarterly

PeriodEndingRevenue
Q2 '262026-06-301.6B
Q1 '262026-03-311.5B
Q4 '252025-12-311.5B
Q3 '252025-09-301.6B
Q2 '252025-06-301.6B
Q1 '252025-03-311.5B
Q4 '242024-12-311.6B
Q3 '242024-09-301.6B
Q2 '242024-06-301.6B
Q1 '242024-03-311.6B
Q4 '232023-12-311.6B
Q3 '232023-09-301.5B
Q2 '232023-06-301.6B
Q1 '232023-03-311.5B
Q4 '222022-12-311.5B
Q3 '222022-09-301.5B
Q2 '222022-06-301.6B
Q1 '222022-03-311.6B
Q4 '212021-12-311.6B
Q3 '212021-09-301.6B

Gross Profit Quarterly

PeriodEndingGross Profit
Q2 '262026-06-30847M
Q1 '262026-03-31783M
Q4 '252025-12-31741M
Q3 '252025-09-30857M
Q2 '252025-06-30874M
Q1 '252025-03-31841M
Q4 '242024-12-31896M
Q3 '242024-09-30923M
Q2 '242024-06-30939M
Q1 '242024-03-31957M
Q4 '232023-12-31915M
Q3 '232023-09-30907M
Q2 '232023-06-30968M
Q1 '232023-03-31958M

Net Income Quarterly

PeriodEndingNet Income
Q2 '262026-06-30108M
Q1 '262026-03-31146M
Q3 '252025-09-30160M
Q2 '252025-06-30145M
Q1 '252025-03-3187M
Q4 '242024-12-31109M
Q3 '242024-09-30359M
Q2 '242024-06-30195M
Q1 '242024-03-31201M
Q4 '232023-12-31546M
Q3 '232023-09-3058M
Q2 '232023-06-30242M
Q1 '232023-03-31177M
Q4 '222022-12-31108M
Q3 '222022-09-30227M
Q2 '222022-06-30234M
Q1 '222022-03-31348M
Q4 '212021-12-31202M
Q3 '212021-09-30323M
Q2 '212021-06-30427M

Cost of Revenue Quarterly

PeriodEndingCost of Revenue
Q2 '262026-06-30711M
Q1 '262026-03-31677M
Q4 '252025-12-31766M
Q3 '252025-09-30745M
Q2 '252025-06-30720M
Q1 '252025-03-31672M
Q4 '242024-12-31696M
Q3 '242024-09-30659M
Q2 '242024-06-30668M
Q1 '242024-03-31665M
Q4 '232023-12-31683M
Q3 '232023-09-30612M
Q2 '232023-06-30640M
Q1 '232023-03-31580M
Q4 '222022-12-31594M
Q3 '222022-09-30551M
Q2 '222022-06-30588M
Q1 '222022-03-31561M
Q4 '212021-12-31599M
Q3 '212021-09-30609M

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q2 '262026-06-30107M
Q1 '262026-03-31225M
Q4 '252025-12-31141M
Q3 '252025-09-30264M
Q2 '252025-06-30220M
Q1 '252025-03-3175M
Q4 '242024-12-31390M
Q3 '242024-09-30141M
Q2 '242024-06-30332M
Q1 '242024-03-3176M
Q4 '232023-12-31397M
Q3 '232023-09-30261M
Q2 '232023-06-3027M
Q1 '232023-03-31114M
Q4 '222022-12-31267M
Q3 '222022-09-30317M
Q2 '222022-06-30151M
Q1 '222022-03-31123M
Q4 '212021-12-3147M
Q3 '212021-09-30368M

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q2 '262026-06-3065M
Q1 '262026-03-31188M
Q4 '252025-12-3196M
Q3 '252025-09-30218M
Q2 '252025-06-30181M
Q1 '252025-03-3143M
Q4 '242024-12-31335M
Q3 '242024-09-3099M
Q2 '242024-06-30300M
Q1 '242024-03-3130M
Q4 '232023-12-31318M
Q3 '232023-09-30206M
Q2 '232023-06-30-44M
Q1 '232023-03-3168M
Q4 '222022-12-31204M
Q3 '222022-09-30262M
Q2 '222022-06-30106M
Q1 '222022-03-3190M
Q4 '212021-12-31-12M
Q3 '212021-09-30332M

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q2 '262026-06-30270.4M
Q1 '262026-03-31262.9M
Q3 '252025-09-30260.7M
Q2 '252025-06-30260.2M
Q1 '252025-03-31261M
Q3 '242024-09-30259.8M
Q2 '242024-06-30258.6M
Q1 '242024-03-31258.4M
Q3 '232023-09-30256.3M
Q2 '232023-06-30256M
Q1 '232023-03-31256.2M
Q3 '222022-09-30255.1M
Q2 '222022-06-30255.2M
Q1 '222022-03-31255.1M
Q3 '212021-09-30254.2M
Q2 '212021-06-30253.8M
Q1 '212021-03-31253.5M
Q3 '202020-09-30253.5M
Q2 '202020-06-30253.5M
Q1 '202020-03-31253.5M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q3 '252025-09-301.91
Q2 '252025-06-302.68
Q1 '252025-03-312.87
Q4 '242024-12-313.32
Q3 '242024-09-305.04
Q2 '242024-06-303.89
Q1 '242024-03-314.09
Q4 '232023-12-314.00
Q3 '232023-09-302.29
Q2 '232023-06-302.95
Q1 '232023-03-312.92
Q4 '222022-12-313.59
Q3 '222022-09-303.96
Q2 '222022-06-304.34
Q1 '222022-03-315.10
Q4 '212021-12-315.32
Q3 '212021-09-305.98
Q2 '212021-06-306.87
Q1 '212021-03-317.33
Q4 '202020-12-318.53